Most Recent Articles by Ben Comer
Forest Labs will acquire Clinical Data for $1.2 billion, and expand its primary care sales forces in preparation for the launch of Viibryd (vilazodone HCI), executives said in a conference call.
Savient Pharmaceuticals launched Krystexxa, an orphan drug for chronic gout, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers.
Health Union, an online health information and social media company, announced the launch of its first website --Migraine.com--intended to foster "interactions about health conditions between and among patients, caregivers, professionals and providers."
Sally Field's winsome smile may have helped to curb declining sales of Roche's Boniva in 2010, but it didn't carry the drug past Warner Chilcott's Actonel, despite a substantially higher DTC spend.
Savient Pharmaceuticals launched Krystexxa (pegloticase), an orphan drug for chronic gout, on Monday, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers, executives said on a conference call.
More Articles by Ben Comer
- Five things for pharma marketers to know: Friday, October 10, 2015
- Digital still not top priority in healthcare: survey
- Six things for pharma marketers to know: Thursday, October 8, 2015
- BI and Lilly launch DTC campaign for Jardiance
- Five things for pharma marketers to know: Wednesday, October 7, 2015
Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.